Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Pillar Biosciences Closes $29.7M Series C Financing Round

Pillar Biosciences Closes $29.7M Series C Financing Round

May 12, 2020
|
staff reporter

NEW YORK – Cancer diagnostic testing firm Pillar Biosciences announced Tuesday that it has closed a $29.7 Series C preferred stock financing round led by ORI Healthcare Fund. It also announced CE marking for its Onco/Reveal Dx lung and colon cancer in vitro diagnostic assay.

The Natick, Massachusetts-based assay developer said it will use the funds to accelerate expansion of its clinical and research-use next-generation sequencing panels and to expand its global commercial reach.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Another Cold Case Arrest

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

Circumventing that Pesky Poison

NPR reports that some insect pests are now becoming resistant to Bt crops.

Not Convened

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

Nature Papers Describe Future Path for Human Genomic Research, Method to Analyze RNA Structure With Nanopore Sequencing, More

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.

Nov
03
Featured Webinar

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Sponsored by
Agilent

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

Nov
05
Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

Sponsored by
Roche

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

Nov
18
Featured Webinar

Rapid WGS: How Rady Children’s Institute Is Increasing Diagnostic Yield and Improving Outcomes

Sponsored by
Genomenon

Rapid whole-genome sequencing (rWGS) is an emerging method that can provide molecular diagnosis in time to alter acute medical or surgical management and improve outcomes in acutely ill children.

What's Popular?

In Molecular Diagnostics

  1. Biodesix Prices $72M IPO

  2. Illumina's ExpansionHunter Software Shows Clinical Promise for STR Expansions

    Premium

  3. UPDATE: Biocartis, Exact Sciences Terminate Oncotype DX Agreement

  4. Exact Sciences Aiming to Make Pan-Cancer Blood Screening Part of Standard Medical Care

    Premium

  5. Strata Oncology Receives Medicare Coverage for NGS Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.